openPR Logo
Press release

EMDEX and ITmedicus release a new free Drug Information App on Android

07-10-2018 11:10 AM CET | Health & Medicine

Press release from: EMDEX

EMDEX App: Free Version on Android

EMDEX App: Free Version on Android

EMDEX Nigeria, in partnership with ITmedicus, is pleased to announce the launch of free EMDEX Drug Information App on Google Play Store. The iOS version will be available soon. The two companies are also working together on several other apps specifically targeting Nigeria's healthcare sector.
This Free version of EMDEX App has several unique functionalities, practice resources & tools including:
•Free CPD/CME program powered by mdBriefCase
•EMDEX RapidRx – Drug Therapy Management Newsletter
•Indication Index, etc.
EMDEX is for healthcare professionals only.
Key features:
•Drugs details (Indications, Dosage & administrations, Contraindications, Precautions & warnings, Pharmacovigilance, Adverse effects, Advice to patients, Nursing action, Drug product descriptions & Pack sizes)
•Search Drugs (Search by Brand name, Generic name or Condition)
•Drugs by Brands (A-Z brands)
•Drugs by Generics (A-Z generics)
•Drugs by Classes
•Drugs by Conditions
•Favourite Drugs (Bookmark any brand names)
•RapidRx (Drug therapy management newsletter)
•Feedback (Can directly post your valuable suggestion, advice & comments)
•Advance search (Can choose different search categories)

EMDEX (Essential Medicines Index) is Nigeria’s trusted source for drug and therapeutic information published since 1991. Based on both the WHO Model Formulary and Nigeria’s Essential Drugs List, EMDEX is unique to Nigeria as it also details over 5000 drug products approved for use in the country

6040 Montevideo Road
Unit 48

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EMDEX and ITmedicus release a new free Drug Information App on Android here

News-ID: 1116796 • Views:

More Releases from EMDEX

EMDEX announces Partnership with StekoDesigns
10-04-2019 | Health & Medicine
EMDEX
EMDEX announces Partnership with StekoDesigns
EMDEX Limited is pleased to announce a new strategic partnership with StekoDesigns effective October 1, 2019. This relationship is established with the objective of: 1. Creating and executing digital marketing strategies for EMDEX products. 2. Building and maintaining a consistent brand image by creating professional and relevant graphic designs on the digital space. These will be reflected on EMDEX publications and social media platforms. StekoDesigns is an agency that helps organizations boost their
EMDEX announces Partnership with Pharmécrit
07-24-2018 | Health & Medicine
EMDEX
EMDEX announces Partnership with Pharmécrit
EMDEX Limited is pleased to announce a new strategic partnership with Pharmécrit effective March 5, 2018. This relationship is established with a sole objective of producing high quality, evidence-based, and up-to-date information about drugs and their therapeutic applications. This will be made available through EMDEX publications to all healthcare professionals in Nigeria, Africa, and the rest of the world. Pharmécrit, a medical communications company, is the new leading medical content contributor
May & Baker and Others Sponsor 2017 Annual Pharmacists Conference in Nigeria
11-06-2017 | Health & Medicine
EMDEX
May & Baker and Others Sponsor 2017 Annual Pharmacists Conference in Nigeria
Umuahia, the capital city of Abia State in southeastern Nigeria, will be hosting over 5000 pharmacists at the 2017th edition of PSN national conference. There will also be exhibitions by pharmaceutical manufacturers and importers from within and outside the country. This annual event is usually the largest gathering of pharmacists and pharmaceutical companies in Africa. LAGOS, Nigeria. November 5, 2017 - The 90th Annual National Conference of the PHARMACEUTICAL SOCIETY OF
11-03-2017 | Health & Medicine
EMDEX
Pemason Pharma Sponsors Drug Information Publication - EMDEX 2018-2019 Edition
Publication of drug information is a costly operation, made more challenging in a harsh economic and resource-limited setting like the sub-Saharan Africa. To sustain its yearly updates and digitize the print editions, EMDEX needed a lifeline in form of sponsorship. Pemason, Nigeria’s leading pharmaceutical firm, promptly said yes to the initiative. The outcome is the onset of a unique partnership that can potentially change the face of healthcare in the

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase